Glaxo Smithlink Consumer Nigeria Plc on Thursday June 11th, 2020 released its financial statement for the three months ended, 31 March, 2020.
The firm recorded a turnover of N16.447 billion, up by 3.44% when compared with the turnover of N15.916 billion reported in third quarter of 2019.
Profit after tax grew by 1.71% to settle at N434 million from N427 million reported same period in2019.
The earnings per share of the firm stands at 363 kobo, up by 1.71% when compared with the earnings per share of 357 kobo reported in the Q3, 2019.
With reference to the share price of N5.65, the P.E ratio of Glaxosmith Nigeria Plc stands at 15.56x with earnings yield of 6.43%.
Glaxosmith grew profit marginally by 1.71% in Q3 2020
Glaxo Smithlink Consumer Nigeria Plc on Thursday June 11th, 2020 released its financial statement for the three months ended, 31 March, 2020.
The firm recorded a turnover of N16.447 billion, up by 3.44% when compared with the turnover of N15.916 billion reported in third quarter of 2019.
Profit after tax grew by 1.71% to settle at N434 million from N427 million reported same period in2019.
The earnings per share of the firm stands at 363 kobo, up by 1.71% when compared with the earnings per share of 357 kobo reported in the Q3, 2019.
With reference to the share price of N5.65, the P.E ratio of Glaxosmith Nigeria Plc stands at 15.56x with earnings yield of 6.43%.